Cited by 99Developmental Biology and Gene RegulationGenomics and Chromatin DynamicsCancer-related Molecular Pathways

The roles and regulation of TBX3 in development and disease

Open access
Khan, Saif F., Damerell, Victoria, Omar, Rehana, Du Toit, Michelle, Khan, Mohsin, Maranyane, Hapiloe Mabaruti, Mlaza, Mihlali, Bleloch, Jenna +5 more·2020·Gene

Abstract

TBX3, a member of the ancient and evolutionary conserved T-box transcription factor family, is a critical developmental regulator of several structures including the heart, mammary glands, limbs and lungs. Indeed, mutations in the human TBX3 lead to ulnar mammary syndrome which is characterized by several clinical malformations including hypoplasia of the mammary and apocrine glands, defects of the upper limb, areola, dental structures, heart and genitalia. In contrast, TBX3 has no known function in adult tissues but is frequently overexpressed in a wide range of epithelial and mesenchymal derived cancers. This overexpression greatly impacts several hallmarks of cancer including bypass of senescence, apoptosis and anoikis, promotion of proliferation, tumour formation, angiogenesis, invasion and metastatic capabilities as well as cancer stem cell expansion. The debilitating consequences of having too little or too much TBX3 suggest that its expression levels need to be tightly regulated. While we have a reasonable understanding of the mutations that result in low levels of functional TBX3 during development, very little is known about the factors responsible for the overexpression of TBX3 in cancer. Furthermore, given the plethora of oncogenic processes that TBX3 impacts, it must be regulating several target genes but to date only a few have been identified and characterised. Interestingly, while there is compelling evidence to support oncogenic roles for TBX3, a few studies have indicated that it may also have tumour suppressor functions in certain contexts. Together, the diverse functional elasticity of TBX3 in development and cancer is thought to involve, in part, the protein partners that it interacts with and this area of research has recently received some attention. This review provides an insight into the significance of TBX3 in development and cancer and identifies research gaps that need to be explored to shed more light on this transcription factor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.gene.2019.144223

Cites

189 of 189 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Proper TBX3 expression directs the embryonic formation of hypothalamus-pituitary, the heart, mammary glands, limbs, and lungs.

    “Proper TBX3 expression directs the embryonic formation of hypothalamus-pituitary, the heart, mammary glands, limbs, and lungs9,10.”

    From Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis (2024) · cites this paper as [9]

    The “Expression and function of TBX3 during development” section says TBX3 plays crucial roles in development of the heart, mammary glands, limbs and lungs. It reports TBX3 expression in developing pituitary glands, but does not establish that it directs formation of the hypothalamic–pituitary axis. The citation therefore supports four of the five listed developmental roles, but not the full claim. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Tbx3 is specifically and dynamically expressed during embryonic organogenesis and its expression is relatively low in adult organs.

    “As a developmental factor, Tbx3 is specifically and dynamically expressed during embryonic organogenesis, while its expression goes relatively low in adult organs9.”

    From Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis (2024) · cites this paper as [9]

    The ‘Expression and function of TBX3 during development’ section (page unavailable) lists numerous developing mouse organs that express Tbx3. The heart, limb and mammary-gland sections also describe changes in where it is expressed as development proceeds. The paper does not establish the claimed general decrease in expression across adult organs; its cancer section compares particular tumors with normal tissue, not adult organs with embryonic organs. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Tbx3 plays fate determination roles for other endoderm-derived organs including the lungs, the liver, and the pancreas.

    “A series of genetic studies have shown Tbx3 plays fate determination roles for other endoderm-derived organs including the lungs, the liver, and the pancreas9.”

    From Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis (2024) · cites this paper as [9]

    The References section cites a study reporting that Tbx3 controls hepatic progenitor-cell fate, supporting the liver part. The Lung development section describes Tbx3’s role in mesenchymal proliferation and branching morphogenesis, not fate determination; the Expression and function section lists pancreatic expression but does not establish a pancreatic fate-determination role. Page numbers are unavailable in our copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Prior reports regarding the regulation of TBX3 levels during development and tumorigenesis mainly focus on transcriptional regulation.

    “Prior reports regarding the regulation of TBX3 levels during development and tumorigenesis mainly focus on the transcriptional regulation9.”

    From Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis (2024) · cites this paper as [9]

    The TBX3 in cancer section reports that c-Myc transcriptionally upregulates TBX3 in chondrosarcoma, and the Mammary gland development section describes signalling pathways that regulate Tbx3 expression. These examples support the focus on regulation of TBX3 levels, but the passages do not establish that prior reports mainly focus on transcriptional regulation across development and tumorigenesis. Page numbers are unavailable in our copy. (LLM, conf=0.77)

    Experimental — accuracy not yet measured
  • Tbx3 is a gene required for embryonic liver development.

    “The transcriptional repressor Tbx3, a gene required for embryonic liver development (Khan et al. 2020;Ludtke et al. 2009;Suzuki et al. 2008)”

    From Hepatocyte Cell Cycle Progression Depends on a Transcriptional Repressor Cascade Downstream of Wnt Signaling (2021) · cites this paper as Khan et al. 2020

    The developmental overview says Tbx3 is expressed in the developing mouse liver, and the cancer section reports that it increases proliferation of hepatic progenitor cells. The References section lists studies finding that Tbx3 promotes liver-bud expansion and controls hepatic progenitor-cell fate, but the review passages do not establish the stronger claim that Tbx3 is required for embryonic liver development. No page numbers are available in our copy. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

9 of the 198 references couldn’t be matched to a known paper.

Research works printed but not linked: 9

  1. Bakker ML, Boukens BJ, Mommersteeg MTM, Brons JF, Wakker V, Moorman AFM, Christoffels VM, 2008 Transcription factor Tbx3 is required for the specification of the atrioventricular conduction system. Circ. Res 102, 1340– 1349. 10.1161/CIRCRESAHA.107.169565. 18467625 · DOI
  2. Chen Z, Lü G, Ji T, 2009 Expression of TBX3 mRNA and its role in the pathogenesis and metastasis of breast cancer. Nan Fang Yi Ke Da Xue Xue Bao 29, 87– 89. 19218121
  3. Dhawan P, Singh AB, Ellis DL, Richmond A, 2002 Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res. 62, 7335– 7342. 12499277
  4. Gilmore AP, 2005 Anoikis. Cell Death Differ. 12, 1473– 1477. 10.1038/sj.cdd.4401723. 16247493 · DOI · Paper page
  5. Han J, Yuan P, Yang H, Zhang J, Soh BS, Li P, Lim SL, Cao S, Tay J, Orlov YL, Lufkin T, Ng H-H, Tam W-L, Lim B, 2010 Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 463, 1096– 1100. 10.1038/nature08735. 20139965 PMC2901797 · DOI · Paper page
  6. Inoue R, Asker C, Klangby U, Pisa P, Wiman KG, 1999 Induction of the humanARF protein by serum starvation. Anticancer Res. 19, 2939– 2943. 10652576
  7. Lohnes D, Mark M, Mendelsohn C, Dollé P, Dierich A, Gorry P, Gansmuller A, Chambon P, 1994 Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development 120, 2723– 2748. 7607067
  8. Mailleux AA, Spencer-Dene B, Dillon C, Ndiaye D, Savona-Baron C, Itoh N, Kato S, Dickson C, Thiery JP, Bellusci S, 2002 Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development 129, 53– 60. 11782400
  9. Weaver M, Dunn NR, Hogan BL, 2000 Bmp4 and Fgf10 play opposing roles during lung bud morphogenesis. Development 127, 2695– 2704. 10821767

Cited by

Sorted by citations

Authors
Khan, S. F., Damerell, V., Omar, R., Du Toit, M., Khan, M., Maranyane, H. M., Mlaza, M., Bleloch, J., Bellis, C., Sahm, B. D. B., Peres, J., ArulJothi, K. N., & Prince, S.
Affiliations
University of Cape Town (ZA)
Corresponding author
Prince, Sharon
Venue
Gene
Publisher
Elsevier BV
Published
2020-02
Volume
726
Pages
144223
ISSN
0378-1119 (ISSN-L)
OpenAlex
W2981580264
Cited by
99
References
198
Citations by year
2026: 9 · 2025: 19 · 2024: 23 · 2023: 19 · 2022: 19 · 2021: 5 · 2020: 5
FWCI
0.65
Type
journal article
Language
en
Open access
Locations
  • Gene (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (GM089820)
  • National Research Foundation
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • South African Medical Research Council
  • Cancer Association of South Africa
  • University of Cape Town
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
TBX3, T-box transcription factor, ulnar-mammary syndrome, developmental regulation, cancer overexpression, oncogenic transcription factor, tumor suppressor function, protein-protein interaction, cancer stem cells, metastasis, senescence evasion, heart development, mammary gland development, limb development, lung development
MeSH terms
Animals, Cell Transformation, Neoplastic, Disease, Humans, Transcription Factors, Gene Expression Regulation, Developmental, T-Box Domain Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review